Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.
2.

Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012-2015).

Sanz JC, Rodríguez-Avial I, Ríos E, García-Comas L, Ordobás M, Cercenado E.

Enferm Infecc Microbiol Clin. 2019 Jun 25. pii: S0213-005X(19)30188-0. doi: 10.1016/j.eimc.2019.05.006. [Epub ahead of print] English, Spanish.

PMID:
31253424
3.

Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact.

López-González L, Viñuela-Prieto JM, Rodriguez-Avial I, Manzano R, Candel FJ.

Rev Esp Quimioter. 2019 Jun;32(3):254-262. Epub 2019 Apr 8.

4.

Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain.

Requena S, Lozano AB, Caballero E, García F, Nieto MC, Téllez R, Fernández JM, Trigo M, Rodríguez-Avial I, Martín-Carbonero L, Miralles P, Soriano V, de Mendoza C; HIV-2 Spanish Study Group .

J Antimicrob Chemother. 2019 May 1;74(5):1357-1362. doi: 10.1093/jac/dkz007.

PMID:
30753573
5.

Useful independent factors for distinguish infection and colonization in patients with urinary carbapenemase-producing Enterobacteriaceae isolation.

López-González L, Candel FJ, Viñuela-Prieto JM, González-Del Castillo J, García AB, Pena I, Rodríguez-Avial I.

Rev Esp Quimioter. 2017 Dec;30(6):450-457. Epub 2017 Nov 7.

6.

Identification of Streptococcus pneumoniae lytA, plyA and psaA genes in pleural fluid by multiplex real-time PCR.

Sanz JC, Ríos E, Rodríguez-Avial I, Ramos B, Marín M, Cercenado E.

Enferm Infecc Microbiol Clin. 2018 Aug - Sep;36(7):428-430. doi: 10.1016/j.eimc.2017.07.007. Epub 2017 Aug 14. English, Spanish.

PMID:
28818481
7.

In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.

López Díaz MC, Ríos E, Rodríguez-Avial I, Simaluiza RJ, Picazo JJ, Culebras E.

Int J Antimicrob Agents. 2017 Aug;50(2):191-196. doi: 10.1016/j.ijantimicag.2017.01.039. Epub 2017 May 31.

PMID:
28577932
8.

Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.

López-Diaz MD, Culebras E, Rodríguez-Avial I, Rios E, Viñuela-Prieto JM, Picazo JJ, Rodríguez-Avial C.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02454-16. doi: 10.1128/AAC.02454-16. Print 2017 Feb.

9.

Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.

Ríos E, López MC, Rodríguez-Avial I, Culebras E, Picazo JJ.

J Med Microbiol. 2017 Feb;66(2):169-174. doi: 10.1099/jmm.0.000399. Epub 2017 Mar 7.

PMID:
27902381
10.

[Update in Infectious Diseases 2016].

Candel FJ, García-García AB, Peñuelas M, García-Alvarez A, Chiarella F, López-González L, García-Salguero C, Lejárraga C, Rodríguez-Avial I.

Rev Esp Quimioter. 2016 Sep;29 Suppl 1:1-5. Review. Spanish.

11.

In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.

Rodríguez-Avial I, Pena I, Picazo JJ, Rodríguez-Avial C, Culebras E.

Int J Antimicrob Agents. 2015 Dec;46(6):616-21. doi: 10.1016/j.ijantimicag.2015.07.021. Epub 2015 Sep 9.

PMID:
26391381
12.

Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?

García-Salguero C, Rodríguez-Avial I, Picazo JJ, Culebras E.

Antimicrob Agents Chemother. 2015 Oct;59(10):5959-66. doi: 10.1128/AAC.00873-15. Epub 2015 Jul 13.

13.

Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.

Ríos E, López MC, Rodríguez-Avial I, Pena I, Picazo JJ.

Microb Drug Resist. 2015 Oct;21(5):512-5. doi: 10.1089/mdr.2015.0039. Epub 2015 May 6.

PMID:
25945693
14.

Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.

Pena I, Picazo JJ, Rodríguez-Avial C, Rodríguez-Avial I.

Int J Antimicrob Agents. 2014 May;43(5):460-4. doi: 10.1016/j.ijantimicag.2014.01.021. Epub 2014 Feb 22.

PMID:
24657043
15.

Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Sanz JC, Rodríguez-Avial I, Ríos E, Ramos B, Cercenado E.

Infection. 2014 Jun;42(3):475-83. doi: 10.1007/s15010-013-0571-3. Epub 2013 Dec 22.

PMID:
24363222
16.

[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].

Rodríguez-Avial C, Rodríguez-Avial I, Hernández E, Picazo JJ.

Rev Esp Quimioter. 2013 Mar;26(1):43-6. Spanish.

17.

Rapid diagnosis of invasive pneumococcal disease in pediatric population.

Picazo JJ, Contreras JR, Ríos E, Culebras E, Rodríguez-Avial I, Méndez C, Betriu C; Heracles Study Group.

J Microbiol Methods. 2013 May;93(2):116-20. doi: 10.1016/j.mimet.2013.03.001. Epub 2013 Mar 13.

PMID:
23499921
18.

Rapid identification of clinical isolates of Bacteroides species by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.

Culebras E, Rodríguez-Avial I, Betriu C, Gómez M, Picazo JJ.

Anaerobe. 2012 Feb;18(1):163-5. doi: 10.1016/j.anaerobe.2011.09.005. Epub 2011 Sep 22.

PMID:
21963387
19.

In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.

Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ.

J Antimicrob Chemother. 2012 Jan;67(1):167-9. doi: 10.1093/jac/dkr403. Epub 2011 Sep 27.

PMID:
21954458
20.

In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain.

Ríos Dueñas E, Rodríguez-Avial I, Picazo JJ.

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1621-5. doi: 10.1007/s10096-011-1340-9. Epub 2011 Jul 26.

PMID:
21786208
21.

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.

Rodríguez-Avial C, Rodríguez-Avial I, Merino P, Picazo JJ.

Clin Microbiol Infect. 2012 Jan;18(1):61-6. doi: 10.1111/j.1469-0691.2011.03482.x. Epub 2011 Jul 1.

22.

Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López-Fabal F, Gómez M; VIRA Study Group.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):373-9. doi: 10.1016/j.diagmicrobio.2011.02.009.

PMID:
21683269
23.

[Methicillin-resistant Staphylococcus aureus: changes in the susceptibility pattern to daptomycin during a 10-year period (2001-2010)].

Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López-Fabal F; Grupo VIRA.

Rev Esp Quimioter. 2011 Jun;24(2):107-11. Spanish.

24.

Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients.

Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, Bouza E.

Clin Microbiol Infect. 2011 Jul;17(7):1094-8. doi: 10.1111/j.1469-0691.2011.03495.x. Epub 2011 Apr 5.

25.

Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009.

Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC; Madrid Streptococcus pneumoniae Microbiological Group.

Antimicrob Agents Chemother. 2011 May;55(5):2469-71. doi: 10.1128/AAC.01380-10. Epub 2011 Mar 7.

26.

Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid.

Picazo J, Ruiz-Contreras J, Hernandez B, Sanz F, Gutierrez A, Cercenado E, Meseguer MA, Delgado-Iribarren A, Rodriguez-Avial I, Méndez C.

Vaccine. 2011 Feb 17;29(9):1770-6. doi: 10.1016/j.vaccine.2010.12.114. Epub 2011 Jan 7.

PMID:
21216317
27.

[Clinical use of rapid assays for the detection of influenza An/H1N1].

Pérez J, Culebras E, Baos E, Alvarez-Buylla A, Rodríguez-Avial I, Candel FJ, Picazo JJ.

Rev Esp Quimioter. 2010 Dec;23(4):215-6. Spanish. No abstract available.

28.

High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum beta-lactamase-producing Escherichia coli in Madrid, Spain.

Ríos E, Rodríguez-Avial I, Rodríguez-Avial C, Hernandez E, Picazo JJ.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):380-3. doi: 10.1016/j.diagmicrobio.2010.03.007.

PMID:
20638608
29.

Comparative in vitro activity of ceftobiprole against Gram-positive cocci.

Betriu C, Culebras E, Gómez M, López-Fabal F, Rodríguez-Avial I, Picazo JJ.

Int J Antimicrob Agents. 2010 Aug;36(2):111-3. doi: 10.1016/j.ijantimicag.2010.04.003.

PMID:
20554163
30.

Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.

Betriu C, Gómez M, López-Fabal F, Culebras E, Rodríguez-Avial I, Picazo JJ.

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1179-81. doi: 10.1007/s10096-010-0974-3. Epub 2010 Jun 4.

PMID:
20521156
31.

Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.

Betriu C, Morales G, Rodríguez-Avial I, Culebras E, Gómez M, López-Fabal F, Picazo JJ.

Antimicrob Agents Chemother. 2010 May;54(5):2212-5. doi: 10.1128/AAC.01653-09. Epub 2010 Feb 22.

32.

Direct serogrouping of Streptococcus pneumoniae strains in clinical samples by use of a latex agglutination test.

Sanz JC, Culebras E, Ríos E, Rodríguez-Avial I, Wilhelmi I, Ramos B, Ordobás M, Picazo JJ.

J Clin Microbiol. 2010 Feb;48(2):593-5. doi: 10.1128/JCM.01651-09. Epub 2009 Dec 9.

33.

Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.

Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López F; VIRA Study Group.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):448-51. doi: 10.1016/j.diagmicrobio.2009.03.020.

PMID:
19631100
34.

[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5. Spanish.

PMID:
19406529
35.

[Comparative study of the in vitro activity of tigecycline against multiresistant Enterococcus faecium isolates].

Betriu C, Rodríguez-Avial I, López F, Picazo JJ.

Enferm Infecc Microbiol Clin. 2009 May;27(5):302-3. doi: 10.1016/j.eimc.2007.12.002. Epub 2009 Apr 22. Spanish. No abstract available.

PMID:
19386389
36.

Diversity of the G3 genes of human rotaviruses in isolates from Spain from 2004 to 2006: cross-species transmission and inter-genotype recombination generates alleles.

Martínez-Laso J, Román A, Rodriguez M, Cervera I, Head J, Rodríguez-Avial I, Picazo JJ.

J Gen Virol. 2009 Apr;90(Pt 4):935-43. doi: 10.1099/vir.0.007807-0. Epub 2009 Mar 4.

PMID:
19264637
37.

Phylogeny of G9 rotavirus genotype: a possible explanation of its origin and evolution.

Martinez-Laso J, Román A, Head J, Cervera I, Rodríguez M, Rodríguez-Avial I, Picazo JJ.

J Clin Virol. 2009 Jan;44(1):52-7. doi: 10.1016/j.jcv.2008.08.022. Epub 2008 Nov 1.

PMID:
18977689
38.

Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence.

López F, Culebras E, Betriú C, Rodríguez-Avial I, Gómez M, Picazo JJ.

Diagn Microbiol Infect Dis. 2010 Jan;66(1):73-7. doi: 10.1016/j.diagmicrobio.2008.06.004. Epub 2008 Jul 23.

PMID:
18653303
39.

Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ.

Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12.

40.

Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain.

Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Picazo JJ.

Int J Antimicrob Agents. 2007 Apr;29(4):478-80. Epub 2007 Feb 12. No abstract available.

PMID:
17296288
41.

[Antimicrobial resistance surveillance: VIRA STUDY 2006].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, Gómez M, López F; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2006 Dec;24(10):617-28. Spanish.

PMID:
17194387
42.

Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.

Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, López F, Alvarez J, Picazo JJ; Spanish Tigecycline Group.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):437-44. Epub 2006 Sep 1.

PMID:
16949245
43.

Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.

Betriu C, Salso S, Sánchez A, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ.

Int J Antimicrob Agents. 2006 Jul;28(1):1-5. Epub 2006 Jun 12.

PMID:
16769202
44.

In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.

Rodríguez-Avial I, Rodríguez-Avial C, López O, Culebras E, Picazo JJ.

Int J Antimicrob Agents. 2006 Apr;27(4):303-6. Epub 2006 Mar 15.

PMID:
16540293
45.

Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).

Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, Picazo JJ.

Diagn Microbiol Infect Dis. 2005 Nov;53(3):221-3. Epub 2005 Oct 21.

PMID:
16243476
46.

Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae.

Culebras E, Rodríguez-Avial I, Betriu C, Picazo JJ.

J Antimicrob Chemother. 2005 Nov;56(5):836-40. Epub 2005 Sep 26.

PMID:
16186169
47.

In vitro activity of tigecycline against Bacteroides species.

Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ.

J Antimicrob Chemother. 2005 Aug;56(2):349-52. Epub 2005 Jun 10.

PMID:
15951353
48.

Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.

Rodriguez-Avial I, Rodriguez-Avial C, López O, Picazo JJ.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):261-4.

PMID:
15893900
49.

In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates.

Betriu C, Gómez M, Rodríguez-Avial I, Culebras E, Picazo JJ.

J Antimicrob Chemother. 2005 May;55(5):809-10. Epub 2005 Mar 24. No abstract available.

PMID:
15790670
50.

Supplemental Content

Loading ...
Support Center